SCHEMBL25723089

SCHEMBL25723089

CC1(C)CC2C3=CCC4[C@@]5(C)CC[C@H](O)[C@](C)(CN)C5CC[C@@]4(C)[C@]3(C)C[C@@H](O)[C@@]2(CN)C[C@@H]1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.54
▸ PTPN1 P18031 7/20 0.52
▸ F3 P13726 4/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ USP2 O75604 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ USP7 Q93009 1/20 0.50
▸ SLCO1B3 Q9NPD5 1/20 0.50
▸ SLCO1B1 Q9Y6L6 1/20 0.50
▸ MAPK1 P28482 1/20 0.48
▸ OXTR P30559 1/20 0.48
▸ AVPR1A P37288 1/20 0.48
▸ CD81 P60033 1/20 0.48
▸ SIRT5 Q9NXA8 1/20 0.48
▸ AKR1B10 O60218 1/20 0.47
▸ AKR1B1 P15121 1/20 0.47
▸ TOP2A P11388 1/20 0.46
▸ CES2 O00748 1/20 0.45
▸ CES1 P23141 1/20 0.45
▸ ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353165 0.87 ALOX5 (0.65) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL25722822 0.85 PTPN1 (0.59) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL25722752 0.83 PTPN1 (0.57) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL1050549 0.78 ALOX5 (0.75) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL5887909 0.77 ALOX5 (0.81) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL5887740 0.77 ALOX5 (0.81) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL26677792 0.77 ALOX5 (0.56) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL16329055 0.77 ALOX5 (0.66) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL1050527 0.76 PTPN1 (0.68) ALOX5PTPN1F3CYP3A4USP2
SCHEMBL15132632 0.76 PTPN1 (0.68) ALOX5PTPN1F3CYP3A4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159436-A1 APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES PACIFIC ARROW LTD (CN) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159436-A1 APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES UACA, BRDT, FLT3 ALOX5 250/4885PTPN1 3361/4885F3 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback